BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9432799)

  • 1. [Current issues of mathematical modeling and advancement in radiology].
    Klepper LIa
    Vopr Onkol; 1997; 43(5):538-41. PubMed ID: 9432799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interactive determination of the parameters of mathematical models in planning radiotherapy of malignant tumors. 3. Method of local adjustment of the parameters of mathematical models (examples of application)].
    Klepper LIa
    Med Tekh; 2001; (1):27-33. PubMed ID: 11244851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The interactive determination of the mathematical model parameters for the planning of the radiation therapy of malignant tumors. 2. A method of adjusting the mathematical model parameters for calculating the tolerance doses and probabilities of the occurrence of radiation complications in body organs and tissues].
    Klepper LIa
    Med Tekh; 2000; (5):36-40. PubMed ID: 11076364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Approximate methods for calculation of the likelihood of radiation complications. The generalized PKLQ method (GPKLQM)].
    Klepper LIa
    Med Tekh; 2002; (5):27-32. PubMed ID: 12512280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interactive determination of the parameters of mathematical models for planning radiotherapy of malignant tumors. I. Mathematical models for calculating dose tolerance, adequate doses and the likelihood of development of radiation complications in normal organs and tissues].
    Klepper LIa
    Med Tekh; 2000; (4):37-41. PubMed ID: 10984881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors of the probability of the occurrence of complications in the radiation therapy of malignant neoplasms].
    Pavlov AS; Datsenko VS; Fadeeva MA; Zamiatin OA; Kizhaev EV
    Vopr Onkol; 1980; 26(3):3-8. PubMed ID: 7368653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
    Lee EK; Fox T; Crocker I
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The mathematical modeling of the optimal dose fields in radiation therapy of malignant tumors. Part 1 (Distance radiotherapy)].
    Klepper LIa
    Med Tekh; 2004; (1):30-7. PubMed ID: 15080005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six Sigma: not for the faint of heart.
    Benedetto AR
    Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy.
    Tsougos I; Mavroidis P; Rajala J; Theodorou K; Järvenpää R; Pitkänen MA; Holli K; Ojala AT; Lind BK; Hyödynmaa S; Kappas C
    Phys Med Biol; 2005 Aug; 50(15):3535-54. PubMed ID: 16030381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Approximate methods for calculation of the likelihood of radiation-induced complications. 1. ACLRC method. 2. CERC method].
    Klepper LIa
    Med Tekh; 2001; (6):12-8. PubMed ID: 11837187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models.
    Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
    Radiother Oncol; 2007 Mar; 82(3):308-16. PubMed ID: 17224197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthesis of radiological models and radiological invariants (constants). (Part 3: synthesis of population-phenomenological models and Klepper model)].
    Klepper LIa
    Med Tekh; 2006; (3):22-6. PubMed ID: 16875141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mathematical modeling of optimal dose fields in radiotherapy of malignant tumors. Part 2 (Contact methods of radiotherapy)].
    Klepper LIa
    Med Tekh; 2004; (4):27-32. PubMed ID: 15455820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis of radiological models and radiological invariants (constants). Part 1].
    Klepper L Ia
    Med Tekh; 2005; (3):27-32. PubMed ID: 16106957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical modeling of drug delivery.
    Siepmann J; Siepmann F
    Int J Pharm; 2008 Dec; 364(2):328-43. PubMed ID: 18822362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis of radiological models and radiological constants. Part 4: Synthesis of population-phenomenological models and Lyman model].
    Klepper LIa
    Med Tekh; 2006; (5):36-40. PubMed ID: 17133945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nonuniform dose distributions in normal body organs and tissues in the radiotherapy of malignant tumors].
    Klepper LIa
    Med Tekh; 1999; (5):6-10. PubMed ID: 10560087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.